EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation

Grishma Hirode iD, Mai Kilany, Steven Pi, Audrey Kim, Mamatha Bhat iD, Rafique Van Uum, Leslie B Lilly, Bettina E Hansen, Jordan J Feld, Nazia Selzner, Harry L A Janssen

Journal of Viral Hepatitis · 2025

DOI: 10.1111/jvh.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Grishma Hirode und 10 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Liver Transplantation, Antiviral Agents, Nucleosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleos(t)ide analogs (NAs) provide prolonged viral suppression with favourable clinical outcomes in chronic hepatitis B (CHB) patients. Characterisation of adverse hepatic events after NA cessation leading to liver transplantation (LT) is vital to the improvement of patient management and safety considerations. This is a retrospective case series of CHB patients who developed hepatic decompensation due to NA discontinuation and were referred for LT. Patients with hepatocellular carcinoma or coinfection were excluded. Of 11 CHB patients included (81.8% clinical jaundice, 63.6% ascites, 54.5% hepatic encephalopathy and 18.2% variceal bleeding), 45.5% underwent LT, 36.4% were waitlisted (1 active, 1 died, 2 delisted of whom 1 died), and 18.2% died after referral during the assessment period. Median age was 55.1 years, 81.8% were male, and 72.7% had cirrhosis at NA cessation. Reasons for NA withdrawal included nonadherence (81.8%) and physician discretion (18.2%). Median time from NA cessation to a decompensating event was 3.2 months, and from the decompensating event to referral was 16.0 days. This study shows that most patients experience decompensations soon after NA cessation and reinforces that patients should not discontinue treatment themselves. Physicians should very carefully select non‐cirrhotic, adherent patients for NA withdrawal, after which close monitoring and timely retreatment are crucial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicLiver TransplantationAntiviral AgentsNucleosidesWithholding TreatmentHumansMaleMiddle AgedFemaleRetrospective StudiesAdultAgedReferral and ConsultationLiver Cirrhosis

Stichwörter der Autor:innen

decompensationfinite therapyhepatitis Bnucleos(t)ide analogtransplantwithdrawal

Substanzen

Antiviral AgentsNucleosides

Autor:innen und Institutionen

  • Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
  • Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Multi-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.
  • Department of Epidemiology and Biostatistics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.

ORCID-Profile: Grishma Hirode, Mamatha Bhat

Zitieren

APA

Hirode, G., Kilany, M., Pi, S., Kim, A., Bhat, M., Van Uum, R., Lilly, L. B., Hansen, B. E., Feld, J. J., Selzner, N., & Janssen, H. L. A. (2025). Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70031

Vancouver

Hirode G, Kilany M, Pi S, Kim A, Bhat M, Van Uum R, et al. Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70031

BibTeX
@article{Hirode2025,
  author = {Hirode, Grishma and Kilany, Mai and Pi, Steven and Kim, Audrey and Bhat, Mamatha and Van Uum, Rafique and Lilly, Leslie B and Hansen, Bettina E and Feld, Jordan J and Selzner, Nazia and Janssen, Harry L A},
  title = {Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation},
  journal = {Journal of Viral Hepatitis},
  year = {2025},
  doi = {10.1111/jvh.70031}
}
Kostenlos starten →